| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0096 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |